{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:31:57Z","timestamp":1789907517437,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.vaccine.2011.11.028","type":"journal-article","created":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T00:50:38Z","timestamp":1321836638000},"page":"180-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Oral vaccination with inactivated influenza vaccine induces cross-protective immunity"],"prefix":"10.1016","volume":"30","author":[{"given":"Fu-Shi","family":"Quan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Compans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"April (1)","key":"10.1016\/j.vaccine.2011.11.028_bib0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2005.12.003","article-title":"Needle-free vaccine delivery","volume":"58","author":"Giudice","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.11.028_bib0010","first-page":"905","article-title":"Immunization without needles","volume":"5","author":"Mitragotri","year":"2005","journal-title":"Nat Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.028_bib0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000234034","article-title":"Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine","volume":"80","author":"Bergmann","year":"1986","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"January (1\u20133)","key":"10.1016\/j.vaccine.2011.11.028_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0168-1656(95)00105-0","article-title":"Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization","volume":"44","author":"Avtushenko","year":"1996","journal-title":"J Biotechnol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.028_bib0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/infdis\/167.1.84","article-title":"Oral immunization with influenza virus in biodegradable microspheres","volume":"167","author":"Moldoveanu","year":"1993","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.028_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines","volume":"59","author":"Cox","year":"2004","journal-title":"Scand J Immunol"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2011.11.028_bib0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0092-1157(84)80012-8","article-title":"Immunization against influenza in humans using an oral enteric-coated killed virus vaccine","volume":"12","author":"Lazzell","year":"1984","journal-title":"J Biol Stand"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2011.11.028_bib0040","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/CDLI.8.3.652-657.2001","article-title":"Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization","volume":"8","author":"Barackman","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"January (7\u20138)","key":"10.1016\/j.vaccine.2011.11.028_bib0045","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0264-410X(01)00452-2","article-title":"Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine","volume":"20","author":"Lu","year":"2002","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.11.028_bib0050","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/infdis\/175.2.352","article-title":"Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine","volume":"175","author":"Katz","year":"1997","journal-title":"J Infect Dis"},{"issue":"November (23)","key":"10.1016\/j.vaccine.2011.11.028_bib0055","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1073\/pnas.91.23.11187","article-title":"Enteric immunization of mice against influenza with recombinant vaccinia","volume":"91","author":"Meitin","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"April (20\u201322)","key":"10.1016\/j.vaccine.2011.11.028_bib0060","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/S0264-410X(00)00537-5","article-title":"Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)","volume":"19","author":"Conacher","year":"2001","journal-title":"Vaccine"},{"issue":"June (27)","key":"10.1016\/j.vaccine.2011.11.028_bib0065","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.vaccine.2009.03.040","article-title":"Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1\/Th2 bias in the immune response and protection against infection","volume":"27","author":"Mann","year":"2009","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.11.028_bib0070","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/jvi.66.2.1162-1170.1992","article-title":"A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization","volume":"66","author":"Pang","year":"1992","journal-title":"J Virol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.11.028_bib0075","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1128\/JVI.01615-07","article-title":"Induction of heterosubtypic immunity to influenza virus by intranasal immunization","volume":"82","author":"Quan","year":"2008","journal-title":"J Virol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.11.028_bib0080","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/JVI.02052-06","article-title":"Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus","volume":"81","author":"Quan","year":"2007","journal-title":"J Virol"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2011.11.028_bib0085","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1128\/JVI.02035-08","article-title":"Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination","volume":"83","author":"Quan","year":"2009","journal-title":"J Virol"},{"issue":"November (1)","key":"10.1016\/j.vaccine.2011.11.028_bib0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-1759(96)00146-9","article-title":"Limiting dilution analysis of virus-specific memory B cells by an ELISPOT assay","volume":"199","author":"Slifka","year":"1996","journal-title":"J Immunol Methods"},{"issue":"December (1)","key":"10.1016\/j.vaccine.2011.11.028_bib0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vaccine.2007.10.045","article-title":"Towards an oral influenza vaccine: comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model","volume":"26","author":"Amorij","year":"2007","journal-title":"Vaccine"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2011.11.028_bib0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2567.2006.02401.x","article-title":"Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Th1) to Th2-type responses","volume":"119","author":"Strid","year":"2006","journal-title":"Immunology"},{"issue":"March (9)","key":"10.1016\/j.vaccine.2011.11.028_bib0105","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1073\/pnas.0807126106","article-title":"Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions","volume":"106","author":"Nagao","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2011.11.028_bib0110","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/j.vaccine.2007.01.106","article-title":"Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin","volume":"25","author":"Bright","year":"2007","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2011.11.028_bib0115","doi-asserted-by":"crossref","first-page":"e7152","DOI":"10.1371\/journal.pone.0007152","article-title":"Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin","volume":"4","author":"Quan","year":"2009","journal-title":"PLoS One"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2011.11.028_bib0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2010.05.034","article-title":"Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles","volume":"405","author":"Song","year":"2010","journal-title":"Virology"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2011.11.028_bib0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00878.x","article-title":"Langerin-expressing dendritic cells in gut-associated lymphoid tissues","volume":"234","author":"Chang","year":"2010","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.028_bib0135","first-page":"43","article-title":"Clinical and immunologic effects following oral immunization against influenza in children in day care and infection susceptible young children","volume":"29","author":"Wiersbitzky","year":"1990","journal-title":"Padiatr Grenzgeb"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.11.028_bib0140","first-page":"312","article-title":"Oral influenza vaccination with live attenuated viruses. 1. Acceptability, immunogenicity and transmissibility","volume":"54","author":"Petrilli","year":"1975","journal-title":"B I Sieroter Milan"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2011.11.028_bib0145","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/JVI.75.11.5141-5150.2001","article-title":"Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection","volume":"75","author":"Tumpey","year":"2001","journal-title":"J Virol"},{"issue":"July (23)","key":"10.1016\/j.vaccine.2011.11.028_bib0150","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1016\/S0264-410X(03)00234-2","article-title":"Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice","volume":"21","author":"Takada","year":"2003","journal-title":"Vaccine"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2011.11.028_bib0155","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1128\/JVI.00207-09","article-title":"Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge","volume":"83","author":"Perrone","year":"2009","journal-title":"J Virol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.11.028_bib0160","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1086\/315337","article-title":"Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant","volume":"181","author":"Gluck","year":"2000","journal-title":"J Infect Dis"},{"issue":"September (1\u20133)","key":"10.1016\/j.vaccine.2011.11.028_bib0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0169-409X(01)00174-0","article-title":"Review of intranasal influenza vaccine","volume":"51","author":"Gluck","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.11.028_bib0170","first-page":"323","article-title":"Oral influenza vaccination with live attenuated viruses. 2. Protective efficacy during a type A(H3N2) epidemic","volume":"54","author":"Petrilli","year":"1975","journal-title":"B I Sieroter Milan"},{"issue":"June (19)","key":"10.1016\/j.vaccine.2011.11.028_bib0175","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.vaccine.2003.11.067","article-title":"Optimisation of a lipid based oral delivery system containing A\/Panama influenza haemagglutinin","volume":"22","author":"Mann","year":"2004","journal-title":"Vaccine"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.11.028_bib0180","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1128\/JVI.02175-09","article-title":"Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection","volume":"84","author":"Prabakaran","year":"2010","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101797X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101797X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:20:22Z","timestamp":1759400422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1101797X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0264410X1101797X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral vaccination with inactivated influenza vaccine induces cross-protective immunity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}